Cargando…
P1185: ANTITUMOR ACTIVITY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED NON-GCB DLBCL WITH EXTRANODAL INVOLVEMENT: A PROSPECTIVE PHASE II STUDY.
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430063/ http://dx.doi.org/10.1097/01.HS9.0000847604.18059.09 |
| _version_ | 1784779644009971712 |
|---|---|
| author | Li, C. Geng, H. Zong, X. Zhou, J. Zhang, Y. Li, J. Jia, S. Wu, D. |
| author_facet | Li, C. Geng, H. Zong, X. Zhou, J. Zhang, Y. Li, J. Jia, S. Wu, D. |
| author_sort | Li, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430063 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94300632022-08-31 P1185: ANTITUMOR ACTIVITY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED NON-GCB DLBCL WITH EXTRANODAL INVOLVEMENT: A PROSPECTIVE PHASE II STUDY. Li, C. Geng, H. Zong, X. Zhou, J. Zhang, Y. Li, J. Jia, S. Wu, D. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430063/ http://dx.doi.org/10.1097/01.HS9.0000847604.18059.09 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Li, C. Geng, H. Zong, X. Zhou, J. Zhang, Y. Li, J. Jia, S. Wu, D. P1185: ANTITUMOR ACTIVITY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED NON-GCB DLBCL WITH EXTRANODAL INVOLVEMENT: A PROSPECTIVE PHASE II STUDY. |
| title | P1185: ANTITUMOR ACTIVITY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED NON-GCB DLBCL WITH EXTRANODAL INVOLVEMENT: A PROSPECTIVE PHASE II STUDY. |
| title_full | P1185: ANTITUMOR ACTIVITY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED NON-GCB DLBCL WITH EXTRANODAL INVOLVEMENT: A PROSPECTIVE PHASE II STUDY. |
| title_fullStr | P1185: ANTITUMOR ACTIVITY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED NON-GCB DLBCL WITH EXTRANODAL INVOLVEMENT: A PROSPECTIVE PHASE II STUDY. |
| title_full_unstemmed | P1185: ANTITUMOR ACTIVITY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED NON-GCB DLBCL WITH EXTRANODAL INVOLVEMENT: A PROSPECTIVE PHASE II STUDY. |
| title_short | P1185: ANTITUMOR ACTIVITY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED NON-GCB DLBCL WITH EXTRANODAL INVOLVEMENT: A PROSPECTIVE PHASE II STUDY. |
| title_sort | p1185: antitumor activity and safety of zanubrutinib combined with r-chop regimen in the treatment of newly diagnosed non-gcb dlbcl with extranodal involvement: a prospective phase ii study. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430063/ http://dx.doi.org/10.1097/01.HS9.0000847604.18059.09 |
| work_keys_str_mv | AT lic p1185antitumoractivityandsafetyofzanubrutinibcombinedwithrchopregimeninthetreatmentofnewlydiagnosednongcbdlbclwithextranodalinvolvementaprospectivephaseiistudy AT gengh p1185antitumoractivityandsafetyofzanubrutinibcombinedwithrchopregimeninthetreatmentofnewlydiagnosednongcbdlbclwithextranodalinvolvementaprospectivephaseiistudy AT zongx p1185antitumoractivityandsafetyofzanubrutinibcombinedwithrchopregimeninthetreatmentofnewlydiagnosednongcbdlbclwithextranodalinvolvementaprospectivephaseiistudy AT zhouj p1185antitumoractivityandsafetyofzanubrutinibcombinedwithrchopregimeninthetreatmentofnewlydiagnosednongcbdlbclwithextranodalinvolvementaprospectivephaseiistudy AT zhangy p1185antitumoractivityandsafetyofzanubrutinibcombinedwithrchopregimeninthetreatmentofnewlydiagnosednongcbdlbclwithextranodalinvolvementaprospectivephaseiistudy AT lij p1185antitumoractivityandsafetyofzanubrutinibcombinedwithrchopregimeninthetreatmentofnewlydiagnosednongcbdlbclwithextranodalinvolvementaprospectivephaseiistudy AT jias p1185antitumoractivityandsafetyofzanubrutinibcombinedwithrchopregimeninthetreatmentofnewlydiagnosednongcbdlbclwithextranodalinvolvementaprospectivephaseiistudy AT wud p1185antitumoractivityandsafetyofzanubrutinibcombinedwithrchopregimeninthetreatmentofnewlydiagnosednongcbdlbclwithextranodalinvolvementaprospectivephaseiistudy |